Moses Jennifer K. 4
4 · Viridian Therapeutics, Inc.\DE · Filed Jun 16, 2023
Insider Transaction Report
Form 4
Moses Jennifer K.
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-14+20,000→ 20,000 totalExercise: $27.67Exp: 2033-06-14→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option vests in full upon the earlier to occur of (i) June 14, 2024 or (ii) the Issuer's 2024 annual meeting of stockholders, subject to Reporting Person's continued service on the Board.